Skip to content

Prospective Evaluation of a Commercially Available Hydrogel Spacer

Clinical Protocol for the Prospective Evaluation of a Commercially Available Hydrogel Spacer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05323747
Acronym
BP-008
Enrollment
20
Registered
2022-04-12
Start date
2020-11-20
Completion date
2022-02-08
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate, Prostate Cancer, Spacer, Perirectal spacer

Brief summary

Dosimetry efficacy evaluation of the hydrogel spacer

Detailed description

Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in 20 males undergoing radiotherapy to treat prostate cancer. Study will utilize pre and post gel insertion CT images to determine the endpoints.

Interventions

OTHERObservation

Assessment of rectal dosimetry change from pre-insertion to post-insertion in subjects with prostate cancer who have undergone radiotherapy with a hydrogel spacer.

Sponsors

BioProtect
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males * At lease 18 years of age * Undergoing external beam or brachy radiation therapy with a hydrogel spacer

Exclusion criteria

* Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension

Design outcomes

Primary

MeasureTime frameDescription
Dosimetry changes1 monthAssessment of rectal radiation exposure as compared between rectal dose volume histograms calculated for pre and post Hydrogel Injection

Secondary

MeasureTime frameDescription
Prostate to rectum spacing1 monthProstate to rectum spacing measurement for evaluation of the perirectal distance post-hydrogel insertion

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026